25 June 2010

Mould may trigger severe asthma

Living in a home with high levels of mould may increase the risk of severe asthma attacks in people with certain gene variants, finds a new study.

Living in a home with high levels of mould may increase the risk of severe asthma attacks in people with certain gene variants, finds a new study.

"We found that the interaction between environmental mould exposure and certain variants of chitinase genes were positively associated with severe asthma exacerbations requiring hospitalisation," lead researcher Ann Wu, an assistant professor at Harvard Medical School and Harvard Pilgrim Health Care Institute, said.

Chitinases, which break down a component in fungi called chitin, are induced during allergic inflammation. It's known that people with asthma have higher expression of certain variants of chitinase.

The study

In this study, Wu and colleagues analysed data from the Childhood Asthma Management Program, a trial that enrolled children between the ages of five and 12 with mild to moderate persistent asthma. The children's homes were classified as having more or less than 25 000 mould colonies per gram of household dust. A level greater than 25 000 is considered high for a home.

The researchers also conducted genetic tests on blood samples taken from the children. They concluded that certain variants of the chitinase gene CHIT1, along with exposure to high levels of mould, are associated with an increased risk of severe asthma attacks.

The study, published online and in an upcoming print issue of the American Journal of Respiratory and Critical Care Medicine, suggests that chitinases may offer a target for new types of asthma treatments. - (HealthDay News, June 2010)


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Asthma Expert

Professor Keertan Dheda has received of several prestigious awards including the 2014 Oppenheimer Award, and has published over 160 peer-reviewed papers and holds 3 patents related to new TB diagnostic or infection control technologies. He serves on the editorial board of the journals PLoS One, the International Journal of Tuberculosis and Lung Disease, American Journal of Respiratory and Critical Medicine, Lancet Respiratory Diseases and Nature Scientific Reports, amongst others.Read his full biography at the University of Cape Town Lung Institute

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules